nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—Tamoxifen—pancreatic cancer	0.0797	0.14	CbGbCtD
Acebutolol—CYP2D6—Tamoxifen—pancreatic cancer	0.0751	0.132	CbGbCtD
Acebutolol—ABCB1—Gemcitabine—pancreatic cancer	0.0687	0.12	CbGbCtD
Acebutolol—ABCB1—Erlotinib—pancreatic cancer	0.0678	0.119	CbGbCtD
Acebutolol—CYP2D6—Erlotinib—pancreatic cancer	0.0639	0.112	CbGbCtD
Acebutolol—ABCB1—Irinotecan—pancreatic cancer	0.0612	0.107	CbGbCtD
Acebutolol—ABCB1—Docetaxel—pancreatic cancer	0.0449	0.0786	CbGbCtD
Acebutolol—ABCB1—Sunitinib—pancreatic cancer	0.0447	0.0782	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—pancreatic cancer	0.0335	0.0586	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—pancreatic cancer	0.0315	0.0552	CbGbCtD
Acebutolol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00052	0.00128	CcSEcCtD
Acebutolol—Chills—Docetaxel—pancreatic cancer	0.000519	0.00127	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000518	0.00127	CcSEcCtD
Acebutolol—Asthenia—Sunitinib—pancreatic cancer	0.000517	0.00127	CcSEcCtD
Acebutolol—Decreased appetite—Irinotecan—pancreatic cancer	0.000516	0.00127	CcSEcCtD
Acebutolol—Dyspnoea—Gemcitabine—pancreatic cancer	0.000516	0.00127	CcSEcCtD
Acebutolol—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000515	0.00126	CcSEcCtD
Acebutolol—Insomnia—Fluorouracil—pancreatic cancer	0.000515	0.00126	CcSEcCtD
Acebutolol—Somnolence—Gemcitabine—pancreatic cancer	0.000514	0.00126	CcSEcCtD
Acebutolol—Affect lability—Doxorubicin—pancreatic cancer	0.000513	0.00126	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000513	0.00126	CcSEcCtD
Acebutolol—Fatigue—Irinotecan—pancreatic cancer	0.000512	0.00126	CcSEcCtD
Acebutolol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000511	0.00126	CcSEcCtD
Acebutolol—Alopecia—Docetaxel—pancreatic cancer	0.000511	0.00125	CcSEcCtD
Acebutolol—Pruritus—Sunitinib—pancreatic cancer	0.00051	0.00125	CcSEcCtD
Acebutolol—Pain—Irinotecan—pancreatic cancer	0.000508	0.00125	CcSEcCtD
Acebutolol—Constipation—Irinotecan—pancreatic cancer	0.000508	0.00125	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000507	0.00125	CcSEcCtD
Acebutolol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000507	0.00125	CcSEcCtD
Acebutolol—Somnolence—Fluorouracil—pancreatic cancer	0.000506	0.00124	CcSEcCtD
Acebutolol—Decreased appetite—Gemcitabine—pancreatic cancer	0.000503	0.00124	CcSEcCtD
Acebutolol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000501	0.00123	CcSEcCtD
Acebutolol—Nausea—Tamoxifen—pancreatic cancer	0.0005	0.00123	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0005	0.00123	CcSEcCtD
Acebutolol—Fatigue—Gemcitabine—pancreatic cancer	0.000499	0.00123	CcSEcCtD
Acebutolol—Pain—Gemcitabine—pancreatic cancer	0.000495	0.00122	CcSEcCtD
Acebutolol—Constipation—Gemcitabine—pancreatic cancer	0.000495	0.00122	CcSEcCtD
Acebutolol—Nausea—Erlotinib—pancreatic cancer	0.000495	0.00122	CcSEcCtD
Acebutolol—Decreased appetite—Fluorouracil—pancreatic cancer	0.000495	0.00122	CcSEcCtD
Acebutolol—Mood swings—Doxorubicin—pancreatic cancer	0.000494	0.00121	CcSEcCtD
Acebutolol—Diarrhoea—Sunitinib—pancreatic cancer	0.000493	0.00121	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000491	0.00121	CcSEcCtD
Acebutolol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00049	0.0012	CcSEcCtD
Acebutolol—Back pain—Docetaxel—pancreatic cancer	0.000487	0.0012	CcSEcCtD
Acebutolol—Pain—Fluorouracil—pancreatic cancer	0.000487	0.0012	CcSEcCtD
Acebutolol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000486	0.00119	CcSEcCtD
Acebutolol—Dizziness—Sunitinib—pancreatic cancer	0.000477	0.00117	CcSEcCtD
Acebutolol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000477	0.00117	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000476	0.00117	CcSEcCtD
Acebutolol—Abdominal pain—Irinotecan—pancreatic cancer	0.00047	0.00115	CcSEcCtD
Acebutolol—Body temperature increased—Irinotecan—pancreatic cancer	0.00047	0.00115	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00047	0.00115	CcSEcCtD
Acebutolol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000469	0.00115	CcSEcCtD
Acebutolol—Vomiting—Sunitinib—pancreatic cancer	0.000459	0.00113	CcSEcCtD
Acebutolol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000457	0.00112	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—pancreatic cancer	0.000455	0.00112	CcSEcCtD
Acebutolol—Rash—Sunitinib—pancreatic cancer	0.000455	0.00112	CcSEcCtD
Acebutolol—Dermatitis—Sunitinib—pancreatic cancer	0.000454	0.00112	CcSEcCtD
Acebutolol—Urticaria—Fluorouracil—pancreatic cancer	0.000452	0.00111	CcSEcCtD
Acebutolol—Headache—Sunitinib—pancreatic cancer	0.000452	0.00111	CcSEcCtD
Acebutolol—Syncope—Docetaxel—pancreatic cancer	0.000451	0.00111	CcSEcCtD
Acebutolol—Body temperature increased—Fluorouracil—pancreatic cancer	0.00045	0.00111	CcSEcCtD
Acebutolol—Palpitations—Docetaxel—pancreatic cancer	0.000445	0.00109	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—pancreatic cancer	0.000443	0.00109	CcSEcCtD
Acebutolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000442	0.00109	CcSEcCtD
Acebutolol—Cough—Docetaxel—pancreatic cancer	0.000439	0.00108	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—pancreatic cancer	0.000437	0.00107	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—pancreatic cancer	0.000434	0.00107	CcSEcCtD
Acebutolol—Chest pain—Docetaxel—pancreatic cancer	0.000428	0.00105	CcSEcCtD
Acebutolol—Arthralgia—Docetaxel—pancreatic cancer	0.000428	0.00105	CcSEcCtD
Acebutolol—Myalgia—Docetaxel—pancreatic cancer	0.000428	0.00105	CcSEcCtD
Acebutolol—Nausea—Sunitinib—pancreatic cancer	0.000428	0.00105	CcSEcCtD
Acebutolol—Asthenia—Irinotecan—pancreatic cancer	0.000426	0.00105	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000425	0.00105	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—pancreatic cancer	0.000422	0.00104	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—pancreatic cancer	0.000421	0.00104	CcSEcCtD
Acebutolol—Sweating—Epirubicin—pancreatic cancer	0.000416	0.00102	CcSEcCtD
Acebutolol—Asthenia—Gemcitabine—pancreatic cancer	0.000415	0.00102	CcSEcCtD
Acebutolol—Confusional state—Docetaxel—pancreatic cancer	0.000414	0.00102	CcSEcCtD
Acebutolol—Oedema—Docetaxel—pancreatic cancer	0.000411	0.00101	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—pancreatic cancer	0.00041	0.00101	CcSEcCtD
Acebutolol—Pruritus—Gemcitabine—pancreatic cancer	0.000409	0.00101	CcSEcCtD
Acebutolol—Diarrhoea—Irinotecan—pancreatic cancer	0.000406	0.000999	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—pancreatic cancer	0.000405	0.000996	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—pancreatic cancer	0.000404	0.000993	CcSEcCtD
Acebutolol—Shock—Docetaxel—pancreatic cancer	0.000404	0.000993	CcSEcCtD
Acebutolol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000403	0.000989	CcSEcCtD
Acebutolol—Pruritus—Fluorouracil—pancreatic cancer	0.000403	0.000989	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—pancreatic cancer	0.000402	0.000987	CcSEcCtD
Acebutolol—Skin disorder—Docetaxel—pancreatic cancer	0.000399	0.00098	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—pancreatic cancer	0.000397	0.000975	CcSEcCtD
Acebutolol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000396	0.000973	CcSEcCtD
Acebutolol—Dizziness—Irinotecan—pancreatic cancer	0.000393	0.000965	CcSEcCtD
Acebutolol—Anorexia—Docetaxel—pancreatic cancer	0.000391	0.000962	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—pancreatic cancer	0.000391	0.00096	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000391	0.00096	CcSEcCtD
Acebutolol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000389	0.000956	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000388	0.000953	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—pancreatic cancer	0.000387	0.000951	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—pancreatic cancer	0.000385	0.000946	CcSEcCtD
Acebutolol—Hypotension—Docetaxel—pancreatic cancer	0.000384	0.000943	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000383	0.000941	CcSEcCtD
Acebutolol—Vomiting—Irinotecan—pancreatic cancer	0.000378	0.000928	CcSEcCtD
Acebutolol—Dizziness—Fluorouracil—pancreatic cancer	0.000376	0.000924	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—pancreatic cancer	0.000376	0.000923	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000375	0.000921	CcSEcCtD
Acebutolol—Rash—Irinotecan—pancreatic cancer	0.000375	0.00092	CcSEcCtD
Acebutolol—Dermatitis—Irinotecan—pancreatic cancer	0.000374	0.000919	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000374	0.000919	CcSEcCtD
Acebutolol—Headache—Irinotecan—pancreatic cancer	0.000372	0.000914	CcSEcCtD
Acebutolol—Insomnia—Docetaxel—pancreatic cancer	0.000371	0.000913	CcSEcCtD
Acebutolol—Paraesthesia—Docetaxel—pancreatic cancer	0.000369	0.000906	CcSEcCtD
Acebutolol—Vomiting—Gemcitabine—pancreatic cancer	0.000368	0.000904	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—pancreatic cancer	0.000367	0.000902	CcSEcCtD
Acebutolol—Dyspnoea—Docetaxel—pancreatic cancer	0.000366	0.0009	CcSEcCtD
Acebutolol—Somnolence—Docetaxel—pancreatic cancer	0.000365	0.000897	CcSEcCtD
Acebutolol—Rash—Gemcitabine—pancreatic cancer	0.000365	0.000896	CcSEcCtD
Acebutolol—Dermatitis—Gemcitabine—pancreatic cancer	0.000365	0.000896	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—pancreatic cancer	0.000363	0.000893	CcSEcCtD
Acebutolol—Headache—Gemcitabine—pancreatic cancer	0.000362	0.000891	CcSEcCtD
Acebutolol—Flushing—Epirubicin—pancreatic cancer	0.000362	0.000889	CcSEcCtD
Acebutolol—Vomiting—Fluorouracil—pancreatic cancer	0.000362	0.000889	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—pancreatic cancer	0.000362	0.000889	CcSEcCtD
Acebutolol—Dyspepsia—Docetaxel—pancreatic cancer	0.000361	0.000888	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000359	0.000882	CcSEcCtD
Acebutolol—Rash—Fluorouracil—pancreatic cancer	0.000359	0.000881	CcSEcCtD
Acebutolol—Dermatitis—Fluorouracil—pancreatic cancer	0.000358	0.000881	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000358	0.00088	CcSEcCtD
Acebutolol—Decreased appetite—Docetaxel—pancreatic cancer	0.000357	0.000877	CcSEcCtD
Acebutolol—Headache—Fluorouracil—pancreatic cancer	0.000356	0.000876	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000355	0.000871	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000354	0.000871	CcSEcCtD
Acebutolol—Fatigue—Docetaxel—pancreatic cancer	0.000354	0.00087	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—pancreatic cancer	0.000354	0.000869	CcSEcCtD
Acebutolol—Nausea—Irinotecan—pancreatic cancer	0.000353	0.000867	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000351	0.000863	CcSEcCtD
Acebutolol—Constipation—Docetaxel—pancreatic cancer	0.000351	0.000863	CcSEcCtD
Acebutolol—Pain—Docetaxel—pancreatic cancer	0.000351	0.000863	CcSEcCtD
Acebutolol—Chills—Epirubicin—pancreatic cancer	0.00035	0.000859	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—pancreatic cancer	0.000348	0.000854	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—pancreatic cancer	0.000344	0.000846	CcSEcCtD
Acebutolol—Nausea—Gemcitabine—pancreatic cancer	0.000344	0.000844	CcSEcCtD
Acebutolol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000338	0.000831	CcSEcCtD
Acebutolol—Nausea—Fluorouracil—pancreatic cancer	0.000338	0.00083	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—pancreatic cancer	0.000336	0.000826	CcSEcCtD
Acebutolol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000336	0.000825	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—pancreatic cancer	0.000335	0.000823	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—pancreatic cancer	0.000334	0.000822	CcSEcCtD
Acebutolol—Back pain—Epirubicin—pancreatic cancer	0.000328	0.000807	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—pancreatic cancer	0.000327	0.000804	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000325	0.000799	CcSEcCtD
Acebutolol—Abdominal pain—Docetaxel—pancreatic cancer	0.000325	0.000798	CcSEcCtD
Acebutolol—Body temperature increased—Docetaxel—pancreatic cancer	0.000325	0.000798	CcSEcCtD
Acebutolol—Chills—Doxorubicin—pancreatic cancer	0.000324	0.000795	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—pancreatic cancer	0.00032	0.000786	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—pancreatic cancer	0.000319	0.000783	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000315	0.000774	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—pancreatic cancer	0.000309	0.00076	CcSEcCtD
Acebutolol—Malaise—Epirubicin—pancreatic cancer	0.000306	0.000752	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—pancreatic cancer	0.000305	0.000749	CcSEcCtD
Acebutolol—Syncope—Epirubicin—pancreatic cancer	0.000304	0.000748	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—pancreatic cancer	0.000304	0.000746	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—pancreatic cancer	0.0003	0.000737	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000298	0.000733	CcSEcCtD
Acebutolol—Cough—Epirubicin—pancreatic cancer	0.000296	0.000728	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—pancreatic cancer	0.000296	0.000727	CcSEcCtD
Acebutolol—Asthenia—Docetaxel—pancreatic cancer	0.000295	0.000724	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000291	0.000716	CcSEcCtD
Acebutolol—Pruritus—Docetaxel—pancreatic cancer	0.000291	0.000714	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—pancreatic cancer	0.000289	0.00071	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—pancreatic cancer	0.000289	0.00071	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—pancreatic cancer	0.000289	0.00071	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—pancreatic cancer	0.000288	0.000707	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000287	0.000705	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—pancreatic cancer	0.000285	0.000701	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—pancreatic cancer	0.000283	0.000696	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—pancreatic cancer	0.000282	0.000693	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—pancreatic cancer	0.000282	0.000692	CcSEcCtD
Acebutolol—Diarrhoea—Docetaxel—pancreatic cancer	0.000281	0.00069	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—pancreatic cancer	0.000279	0.000686	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—pancreatic cancer	0.000277	0.000682	CcSEcCtD
Acebutolol—Oedema—Epirubicin—pancreatic cancer	0.000277	0.000681	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000276	0.000678	CcSEcCtD
Acebutolol—Cough—Doxorubicin—pancreatic cancer	0.000274	0.000673	CcSEcCtD
Acebutolol—Shock—Epirubicin—pancreatic cancer	0.000272	0.00067	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000272	0.000667	CcSEcCtD
Acebutolol—Dizziness—Docetaxel—pancreatic cancer	0.000272	0.000667	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—pancreatic cancer	0.000269	0.000661	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000268	0.000658	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—pancreatic cancer	0.000267	0.000657	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—pancreatic cancer	0.000267	0.000657	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—pancreatic cancer	0.000267	0.000657	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—pancreatic cancer	0.000266	0.000655	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000265	0.000652	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—pancreatic cancer	0.000264	0.000649	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—pancreatic cancer	0.000264	0.000649	CcSEcCtD
Acebutolol—Vomiting—Docetaxel—pancreatic cancer	0.000261	0.000641	CcSEcCtD
Acebutolol—Rash—Docetaxel—pancreatic cancer	0.000259	0.000636	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—pancreatic cancer	0.000259	0.000636	CcSEcCtD
Acebutolol—Dermatitis—Docetaxel—pancreatic cancer	0.000259	0.000636	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—pancreatic cancer	0.000258	0.000635	CcSEcCtD
Acebutolol—Headache—Docetaxel—pancreatic cancer	0.000257	0.000632	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—pancreatic cancer	0.000256	0.00063	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000252	0.00062	CcSEcCtD
Acebutolol—Shock—Doxorubicin—pancreatic cancer	0.000252	0.000619	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000251	0.000618	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—pancreatic cancer	0.000251	0.000616	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—pancreatic cancer	0.000249	0.000612	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—pancreatic cancer	0.000249	0.000611	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000248	0.000609	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—pancreatic cancer	0.000247	0.000607	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—pancreatic cancer	0.000246	0.000605	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—pancreatic cancer	0.000244	0.0006	CcSEcCtD
Acebutolol—Nausea—Docetaxel—pancreatic cancer	0.000244	0.000599	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—pancreatic cancer	0.000244	0.000599	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—pancreatic cancer	0.000241	0.000592	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—pancreatic cancer	0.000239	0.000588	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000239	0.000588	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—pancreatic cancer	0.000239	0.000587	CcSEcCtD
Acebutolol—Pain—Epirubicin—pancreatic cancer	0.000237	0.000582	CcSEcCtD
Acebutolol—Constipation—Epirubicin—pancreatic cancer	0.000237	0.000582	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000233	0.000574	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—pancreatic cancer	0.000232	0.00057	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—pancreatic cancer	0.00023	0.000565	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000228	0.000561	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000228	0.000561	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—pancreatic cancer	0.000228	0.00056	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000226	0.000556	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000226	0.000554	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000223	0.000547	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000221	0.000544	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—pancreatic cancer	0.000221	0.000543	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—pancreatic cancer	0.00022	0.000541	CcSEcCtD
Acebutolol—Pain—Doxorubicin—pancreatic cancer	0.000219	0.000538	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—pancreatic cancer	0.000219	0.000538	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—pancreatic cancer	0.000219	0.000538	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—pancreatic cancer	0.000219	0.000538	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000211	0.000519	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00021	0.000515	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—pancreatic cancer	0.000204	0.0005	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000203	0.000498	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000203	0.000498	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—pancreatic cancer	0.000199	0.000488	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—pancreatic cancer	0.000196	0.000481	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—pancreatic cancer	0.00019	0.000466	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—pancreatic cancer	0.000184	0.000452	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—pancreatic cancer	0.000183	0.00045	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—pancreatic cancer	0.000181	0.000445	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—pancreatic cancer	0.000176	0.000433	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000175	0.000431	CcSEcCtD
Acebutolol—Rash—Epirubicin—pancreatic cancer	0.000175	0.000429	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—pancreatic cancer	0.000174	0.000429	CcSEcCtD
Acebutolol—Headache—Epirubicin—pancreatic cancer	0.000174	0.000426	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—pancreatic cancer	0.000169	0.000416	CcSEcCtD
Acebutolol—Nausea—Epirubicin—pancreatic cancer	0.000165	0.000404	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—pancreatic cancer	0.000163	0.0004	CcSEcCtD
Acebutolol—Rash—Doxorubicin—pancreatic cancer	0.000162	0.000397	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—pancreatic cancer	0.000161	0.000397	CcSEcCtD
Acebutolol—Headache—Doxorubicin—pancreatic cancer	0.000161	0.000394	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—pancreatic cancer	0.000152	0.000374	CcSEcCtD
Acebutolol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	3.07e-05	0.0014	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	3.07e-05	0.0014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	3.05e-05	0.00139	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	3.05e-05	0.00139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	3.01e-05	0.00137	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	3.01e-05	0.00137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	2.96e-05	0.00135	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	2.95e-05	0.00134	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.94e-05	0.00134	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	2.9e-05	0.00132	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	2.89e-05	0.00132	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	2.86e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	2.85e-05	0.0013	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TYMP—pancreatic cancer	2.85e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.84e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	2.83e-05	0.00129	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	2.8e-05	0.00128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	2.79e-05	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	2.79e-05	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.78e-05	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	2.74e-05	0.00125	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	2.69e-05	0.00122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	2.69e-05	0.00122	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.68e-05	0.00122	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	2.67e-05	0.00122	CbGpPWpGaD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.66e-05	0.00121	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	2.63e-05	0.0012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	2.63e-05	0.0012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	2.63e-05	0.0012	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.61e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	2.61e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	2.61e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	2.57e-05	0.00117	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	2.56e-05	0.00117	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	2.56e-05	0.00117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	2.54e-05	0.00116	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	2.52e-05	0.00115	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	2.49e-05	0.00113	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	2.46e-05	0.00112	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	2.46e-05	0.00112	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	2.42e-05	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	2.4e-05	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	2.37e-05	0.00108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	2.33e-05	0.00106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	2.33e-05	0.00106	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GLP1R—pancreatic cancer	2.3e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	2.28e-05	0.00104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	2.28e-05	0.00104	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.26e-05	0.00103	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—DPYD—pancreatic cancer	2.26e-05	0.00103	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	2.22e-05	0.00101	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.2e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	2.17e-05	0.000991	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	2.17e-05	0.000987	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	2.17e-05	0.000987	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	2.16e-05	0.000987	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	2.14e-05	0.000978	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	2.13e-05	0.000971	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	2.12e-05	0.000966	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	2.12e-05	0.000966	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	2.12e-05	0.000965	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.12e-05	0.000965	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.1e-05	0.000957	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	2.08e-05	0.00095	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.08e-05	0.000947	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	2.07e-05	0.000942	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.04e-05	0.000932	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	2.04e-05	0.000928	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.02e-05	0.000922	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	2.02e-05	0.000921	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	1.99e-05	0.000908	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.97e-05	0.000899	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	1.94e-05	0.000885	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	1.93e-05	0.00088	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	1.92e-05	0.000874	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ARG2—pancreatic cancer	1.91e-05	0.000871	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	1.9e-05	0.000866	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	1.89e-05	0.000861	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	1.88e-05	0.000855	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	1.84e-05	0.000839	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	1.84e-05	0.000839	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.83e-05	0.000834	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	1.8e-05	0.000821	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	1.8e-05	0.000821	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.8e-05	0.000821	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.78e-05	0.000812	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	1.68e-05	0.000768	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TYMP—pancreatic cancer	1.67e-05	0.000761	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.66e-05	0.000757	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CD44—pancreatic cancer	1.66e-05	0.000757	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	1.65e-05	0.000751	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	1.65e-05	0.000751	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	1.64e-05	0.000748	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.64e-05	0.000747	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.63e-05	0.000745	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.62e-05	0.000741	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—HRAS—pancreatic cancer	1.62e-05	0.000739	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	1.61e-05	0.000735	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	1.61e-05	0.000732	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.6e-05	0.000731	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GCG—pancreatic cancer	1.59e-05	0.000726	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.57e-05	0.000717	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	1.55e-05	0.000708	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.53e-05	0.000696	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	1.52e-05	0.000693	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.51e-05	0.00069	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.51e-05	0.000688	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	1.5e-05	0.000684	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—STK11—pancreatic cancer	1.5e-05	0.000682	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.48e-05	0.000673	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	1.47e-05	0.000669	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.46e-05	0.000666	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	1.43e-05	0.000653	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.43e-05	0.000651	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	1.41e-05	0.000643	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	1.4e-05	0.000639	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.39e-05	0.000634	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	1.38e-05	0.000629	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.35e-05	0.000614	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.35e-05	0.000614	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.33e-05	0.000604	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—DPYD—pancreatic cancer	1.32e-05	0.000604	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.3e-05	0.000591	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TYMS—pancreatic cancer	1.29e-05	0.000587	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.27e-05	0.00058	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.27e-05	0.000578	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.26e-05	0.000573	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.25e-05	0.000569	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.24e-05	0.000568	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	1.24e-05	0.000563	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.22e-05	0.000558	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	1.21e-05	0.000551	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	1.21e-05	0.00055	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.2e-05	0.000545	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.18e-05	0.00054	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	1.18e-05	0.000538	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.16e-05	0.000527	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.14e-05	0.000518	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.13e-05	0.000515	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	1.11e-05	0.000506	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	1.09e-05	0.000495	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	1.06e-05	0.000482	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—pancreatic cancer	1.05e-05	0.000477	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	1.03e-05	0.000472	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	1.01e-05	0.000461	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	1.01e-05	0.00046	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	9.89e-06	0.000451	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	9.87e-06	0.00045	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	9.87e-06	0.00045	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CD44—pancreatic cancer	9.73e-06	0.000444	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	9.67e-06	0.000441	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	9.66e-06	0.00044	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	9.46e-06	0.000431	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	9.45e-06	0.000431	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCG—pancreatic cancer	9.33e-06	0.000425	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	9.2e-06	0.000419	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CD44—pancreatic cancer	9.17e-06	0.000418	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARG—pancreatic cancer	9.12e-06	0.000416	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	9.11e-06	0.000415	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	9e-06	0.00041	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	8.91e-06	0.000406	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	8.91e-06	0.000406	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	8.91e-06	0.000406	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	8.81e-06	0.000401	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCG—pancreatic cancer	8.79e-06	0.000401	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—STK11—pancreatic cancer	8.77e-06	0.0004	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	8.72e-06	0.000397	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	8.72e-06	0.000397	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	8.61e-06	0.000393	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	8.31e-06	0.000379	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—STK11—pancreatic cancer	8.27e-06	0.000377	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	8.12e-06	0.00037	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	7.94e-06	0.000362	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	7.83e-06	0.000357	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.76e-06	0.000354	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	7.67e-06	0.00035	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	7.66e-06	0.000349	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.59e-06	0.000346	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TYMS—pancreatic cancer	7.55e-06	0.000344	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	7.5e-06	0.000342	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	7.24e-06	0.00033	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—pancreatic cancer	7.17e-06	0.000327	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TYMS—pancreatic cancer	7.11e-06	0.000324	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.04e-06	0.000321	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.89e-06	0.000314	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	6.83e-06	0.000311	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	6.68e-06	0.000304	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	6.56e-06	0.000299	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	6.52e-06	0.000297	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	6.42e-06	0.000293	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	6.38e-06	0.000291	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	6.34e-06	0.000289	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	6.28e-06	0.000286	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—pancreatic cancer	6.26e-06	0.000285	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	6.2e-06	0.000283	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	6.14e-06	0.00028	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—pancreatic cancer	6.14e-06	0.00028	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	6.11e-06	0.000279	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	6.05e-06	0.000276	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	5.98e-06	0.000273	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	5.93e-06	0.000271	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	5.92e-06	0.00027	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	5.9e-06	0.000269	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	5.8e-06	0.000265	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—pancreatic cancer	5.78e-06	0.000264	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	5.77e-06	0.000263	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	5.75e-06	0.000262	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	5.63e-06	0.000257	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—pancreatic cancer	5.54e-06	0.000253	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	5.47e-06	0.000249	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	5.35e-06	0.000244	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARG—pancreatic cancer	5.35e-06	0.000244	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	5.33e-06	0.000243	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	5.28e-06	0.000241	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	5.26e-06	0.00024	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.22e-06	0.000238	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	5.21e-06	0.000238	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	5.16e-06	0.000235	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	5.15e-06	0.000235	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.04e-06	0.00023	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	4.9e-06	0.000223	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	4.89e-06	0.000223	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—pancreatic cancer	4.87e-06	0.000222	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	4.8e-06	0.000219	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	4.79e-06	0.000219	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	4.78e-06	0.000218	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	4.69e-06	0.000214	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.59e-06	0.000209	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	4.53e-06	0.000207	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	4.43e-06	0.000202	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	4.41e-06	0.000201	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.24e-06	0.000193	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.21e-06	0.000192	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	4.16e-06	0.00019	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	4.07e-06	0.000186	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	4.03e-06	0.000184	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4e-06	0.000182	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.96e-06	0.000181	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	3.94e-06	0.00018	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	3.85e-06	0.000176	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	3.77e-06	0.000172	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—pancreatic cancer	3.67e-06	0.000167	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—pancreatic cancer	3.61e-06	0.000164	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.46e-06	0.000158	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	3.4e-06	0.000155	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	3.33e-06	0.000152	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.59e-06	0.000118	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.44e-06	0.000111	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—pancreatic cancer	2.11e-06	9.64e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.99e-06	9.08e-05	CbGpPWpGaD
